Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1307"

PredicateValue (sorted: default)
rdfs:label
rdf:type
?:Evidence_enzyme_system
?:Evidence_type
?:content
"Metabolism and Excretion Ranolazine is metabolized mainly by CYP3A and, to a lesser extent, by CYP2D6. Following a single oral dose of ranolazine solution, approximately 75% of the dose is excreted in urine and 25% in feces. Ranolazine is metabolized rapidly and extensively in the liver and intestine; less than 5% is excreted unchanged in urine and feces. The pharmacologic activity of the metabolites has not been well characterized."
dc:creator
dc:date
"09/24/2009 15:47:51"
rdfs:seeAlso

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ ranolazine_primary_total_clearance_mechanism_Metabolic_Clearance, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1503 }

Context graph